We use cookies and similar technologies to make this site work properly and to analyse traffic and optimise your browsing experience. By continuing to browse the site, you agree to the use of such cookies. Learn more
Based on solid technological research and development capabilities and rich manufacturing experience, Lynmou Medical has rapidly achieved product certification. The self-developed and manufactured full HD electronic endoscopy system VC-1600 series, as well as electronic upper and lower gastrointestinal endoscopes, were officially certified in April and May this year. Lynmou has innovatively proposed the concept of "Full-Scenario imaging", the four special light imaging modes —HLI, SVI, TCI, and DHI—comprehensively covering the imaging needs of various clinical scenarios, providing professional imaging solutions for screening, diagnosis, and treatment of early gastrointestinal cancer throughout the entire process.
With the introduction of multiple national policies supporting the construction of primary healthcare resources, the continuous approval of company products, and strong capital support, Lynmou Medical, under the guidance of the concept of precise diagnosis and treatment, will continue to launch flexible endoscope departmental solutions to further enhance surgical efficiency and safety.. At the same time, Lynmou Medical is also targeting overseas markets by leveraging domestic and international expert resources and academic exchanges to create an ecological network and expand its presence abroad. The company is committed to building a global layout, gradually bringing a new generation of Chinese-manufactured endoscopes to the international stage.
The product has been certified and the company has simultaneously completed Pre-A financing of tens of millions of RMB. This round of financing will be used to promote the commercialization of the certified products, as well as further strengthen and supplement the company's endoscopic product portfolio, and enhance its comprehensive competitive advantage.
Regarding the completion of this round of financing, the management of Lynmou Medical stated: "Lynmou has always been committed to promoting the development and penetration of flexible endoscopes in China. Since our establishment, we have built a research and development system based on the underlying logic of product technology, continuously refining product details to provide higher quality endoscopic products for clinics and patients, enabling more at-risk groups to benefit from endoscopic diagnosis and treatment. In the future, Lynmou Medical will continue to adhere to the path of innovation, dedicated to the continuous optimization and upgrade of technology, promoting the transformation from 'Made in China to Created in China,' from 'Chinese Speed to Chinese Quality,' and from 'Chinese Products to Chinese Brands,' contributing greater power to the ongoing progress of the medical industry."